In addition, many of the interleukins (ILs) including IL-6, IL-17, IL-23, and IL-26, among others, have been implicated in IBD pathogenesis and its complications [8,9,10], while IL-10 signaling through its receptors plays a protective role against IBD development [11,12,13]. This evidence concerns the gene IL17A and inflammatory bowel disease.